Publication

Article

Contagion

November 2014
Volume1
Issue 3

Diarrhea Superbug Infections Double

Author(s):

From 2001 to 2010, the infection rate of a particular intestinal "superbug" has doubled, with increases in mortality rates and length of hospital stays reflecting this trend.

From 2001 to 2010, the infection rate of an intestinal superbug has doubled, with increases in mortality rates and length of hospital stays reflecting this trend, suggested research in the American Journal of Infection Control (AJIC).

Clostridium difficile (C. difficile) infections, which commonly induce diarrhea, has become a public health concern. Linked to 14,000 deaths annually, C. difficile is the top bacteria responsible for healthcare-associated infections.

Alarmingly, over-prescription of antibiotics is highly culpable for the increase of infections. According to the Centers for Disease Control and Prevention (CDC), a 30% decrease in the use of high-risk, broad-spectrum antibiotics would lover C. difficile infections (CDI) by 26%. As a result, the White House has prioritized re-educating clinicians on antibiotics, an Elsevier statement noted.

For their study, researchers conducted an analysis of US National Hospital Discharge Surveys from 2001-2010, and honed in on records involving CDIs.

Of the 2.2 million CDI discharges occurring during the study period, 33 and 67% of patients were treated for primary and secondary CDI, respectively.

“The overall in-hospital mortality rate was 7.1% (n=154,184) for the study period. Mortality increased slightly over the study period, from 6.6% in 2001 to 7.2% in 2010. Median hospital LOS was 8 days (interquartile range, 4-14 days), and remained stable over the study period,” the authors wrote.

Furthermore, lead author Kelly Reveles, PharmD, PhD said they found 2008 was the peak for CDI, with only a minor decline through 2010. Reveles attributed the decline to improved education new programs involving antibiotic prescription, infection control, and hygiene.

“The results of our study underscore the importance of directing resources to the prevention of CDI, as well as developing public policy for reducing the incidence of these in infections in hospitals worldwide,” the investigators said.

Related Videos
Using Microbiomes to Diagnose Ventilator-Associated Pneumonia
Tailoring Chest Pain Diagnostics to Patients, with Kyle Fortman, PA-C, MBA
Solutions to Prevent Climate Change-Related Illness, with Janelle Bludhorn, PA-C
Kyle Fortman, PA-C, MBA: Troponin and Heart Injury Risk Screening Recommendations
What Should the American Academy of Physician Associates Focus on in 2025?
The Rising Rate of Heat-Related Illness, with Janelle Bludhorn, PA-C
Nanette B. Silverberg, MD: Uncovering Molluscum Epidemiology
A Year of RSV Highs and Lows, with Tina Tan, MD
Ryan A. Smith, MD: RSV Risk in Patients with IBD
Mikkael Sekeres, MD:
© 2024 MJH Life Sciences

All rights reserved.